Cornyn Positions As Drug Pricing Policy Player, Looks To 2020

The Senate Finance Committee kicks off its first hearing on prescription drug pricing Tuesday (Jan. 29), but Sen. John Cornyn (R-TX) already tweeted that a future topic of investigation will be abuses of the rebate system by pharmacy benefit managers -- an announcement that would typically be made by committee chairman Sen. Chuck Grassley (R-IA). Cornyn’s recent active role in drug pricing signals that he is seeking to be more involved in the issue as he prepares for a potentially...